Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V
Clinical trial NCT00097396 · COMPLETED
Trial details
- NCT number
- NCT00097396
- Sponsor
- DynPort Vaccine Company LLC, A GDIT Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2006-07-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.